Description
This engineered triple-receptor agonist peptide engages the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors concurrently, providing a unique tool for studying integrated metabolic signaling across incretin and counter-regulatory pathways. For research use only.
- Tri-Agonist Receptor Pharmacology: Investigated for simultaneous activation of GIPR, GLP-1R, and GCGR signaling cascades and the resulting synergistic effects on energy expenditure and glucose homeostasis.
- Appetite & Satiety Circuit Modulation: Studied for central nervous system effects on hypothalamic POMC/AgRP neuron activity and brainstem GLP-1R-mediated satiety signaling.
- Hepatic Lipid Metabolism: Explored for glucagon-receptor-driven enhancement of hepatic fatty acid oxidation and ketogenesis in metabolic research models.









Reviews
There are no reviews yet.